Literature DB >> 18392207

Treatment resistant psychosis in an adolescent with scoliosis and a history of early feeding difficulties.

Hilary Le Page1.   

Abstract

Entities:  

Year:  2006        PMID： 18392207      PMCID： PMC2277307     

Source DB:  PubMed          Journal:  J Can Acad Child Adolesc Psychiatry        ISSN： 1719-8429


× No keyword cloud information.
  9 in total

1.  Late-onset psychosis in the velo-cardio-facial syndrome.

Authors:  R J Shprintzen; R Goldberg; K J Golding-Kushner; R W Marion
Journal:  Am J Med Genet       Date:  1992-01-01

2.  Scoliosis in velo-cardio-facial syndrome.

Authors:  Eva Morava; Yves Lacassie; Andrew King; Tamas Illes; Michael Marble
Journal:  J Pediatr Orthop       Date:  2002 Nov-Dec       Impact factor: 2.324

3.  Intelligence and psychosocial adjustment in velocardiofacial syndrome: a study of 37 children and adolescents with VCFS.

Authors:  A Swillen; K Devriendt; E Legius; B Eyskens; M Dumoulin; M Gewillig; J P Fryns
Journal:  J Med Genet       Date:  1997-06       Impact factor: 6.318

Review 4.  Velo-cardio-facial syndrome: a model for understanding the genetics and pathogenesis of schizophrenia.

Authors:  K C Murphy; M J Owen
Journal:  Br J Psychiatry       Date:  2001-11       Impact factor: 9.319

5.  Velo-cardio-facial syndrome: Implications of microdeletion 22q11 for schizophrenia and mood disorders.

Authors:  P D Arnold; J Siegel-Bartelt; C Cytrynbaum; I Teshima; R Schachar
Journal:  Am J Med Genet       Date:  2001-05-08

Review 6.  Annotation: velo-cardio-facial syndrome.

Authors:  K C Murphy
Journal:  J Child Psychol Psychiatry       Date:  2005-06       Impact factor: 8.982

7.  Bipolar spectrum disorders in patients diagnosed with velo-cardio-facial syndrome: does a hemizygous deletion of chromosome 22q11 result in bipolar affective disorder?

Authors:  D F Papolos; G L Faedda; S Veit; R Goldberg; B Morrow; R Kucherlapati; R J Shprintzen
Journal:  Am J Psychiatry       Date:  1996-12       Impact factor: 18.112

8.  The velo-cardio-facial (Shprintzen) syndrome. Clinical variability in eight patients.

Authors:  P Meinecke; F A Beemer; A Schinzel; T Kushnick
Journal:  Eur J Pediatr       Date:  1986-12       Impact factor: 3.183

9.  Phenotype of the 22q11.2 deletion in individuals identified through an affected relative: cast a wide FISHing net!

Authors:  D M McDonald-McGinn; M K Tonnesen; A Laufer-Cahana; B Finucane; D A Driscoll; B S Emanuel; E H Zackai
Journal:  Genet Med       Date:  2001 Jan-Feb       Impact factor: 8.822
  9 in total
  2 in total

1.  Response to clozapine in a clinically identifiable subtype of schizophrenia.

Authors:  Nancy J Butcher; Wai Lun Alan Fung; Laura Fitzpatrick; Alina Guna; Danielle M Andrade; Anthony E Lang; Eva W C Chow; Anne S Bassett
Journal:  Br J Psychiatry       Date:  2015-03-05       Impact factor: 9.319

2.  Adverse effects of antipsychotic medication in patients with 22q11.2 deletion syndrome: A systematic review.

Authors:  Janna de Boer; Erik Boot; Lissa van Gils; Therese van Amelsvoort; Janneke Zinkstok
Journal:  Am J Med Genet A       Date:  2019-08-13       Impact factor: 2.802
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.